Vera Therapeutics Inc. has announced the allocation of inducement awards to seventeen new employees under its Inducement Plan, as per Nasdaq Listing Rule 5635(c)(4). The awards, approved by the Compensation Committee on June 3, 2025, include non-qualified stock options for 124,000 shares of Class A common stock and restricted stock units (RSUs) for 65,925 shares. The stock options have an exercise price of $30.91, aligning with Vera's closing trading price on the grant date, and will vest over four years. The RSUs will also vest over four years, with specific vesting schedules outlined and contingent on continued employment with Vera.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.